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Transdermal drug delivery system (TDDS) is defined as 
a dosage form, which when applied to the skin, deliver 
the drug through the skin at control rate to the systemic 
circulation1. Currently transdermal delivery is one of the 
most promising methods for drug application. Increasing 
number of drugs are being added to the list of therapeutic 
agents that can be delivered to the systemic circulation 
via skin2. Transdermal delivery not only provides 
controlled, constant administration of the drug but also 
allows continuous input of drugs with short half lives and 
eliminates pulsed entry into systemic circulation which 
often causes undesirable side effects.  Transdermal 
delivery provides a leading edge over oral route and 
injectables by avoiding first pass metabolism and 
increasing patient compliance respectively3. Transdermal 
delivery involves the passage of the drug molecule from 
the skin surface into the stratum corneum under the 
influence of a concentration gradient and its subsequent 
diffusion through the stratum corneum into the blood 
circulation. The stratum corneum provides the greatest 
resistance to penetration and it is the rate limiting step in 
percutaneous absorption. Therefore transdermal delivery 
requires penetration enhancers to penetrate the drug 
through the skin. They facilitate the absorption of the 
drug through the skin by temporarily diminishing the 
impermeability of the skin4. Several researchers have 
studied the effect of combination of penetration 
enhancers like physical, chemical, and natural 
penetration enhancers to assess the plausibility of 
deriving synergistic benefits. Use of a combination of 
penetration enhancers is reported to mutually enhance 
the safety and efficacy of the drug by acting 
synergistically
5
. The main objective of the study is to 
review the synergistic effect of various physical, 
chemical and natural penetration enhancers on the 
penetration and efficacy of the drug through transdermal 
route. 
Advantages of Transdermal Drug Delivery System 
 
Transdermal Drug delivery system offers many 
advantages over the conventional dosage forms notably 
avoidance of hepatic first–pass metabolism, maintains 
constant blood level for longer period of time, offers less 
frequency of administration, decreases the dose to be 
administered, decreases unwanted side effects, the drug 
can be withdrawn in case of toxicity, minimizes inter and 
intra patient variability, increases patient compliance and 
offers large area of application in comparison with the 
buccal or nasal cavity6. 
Limitation with Transdermal Drug Delivery System 
The outermost layer of the skin i.e. the stratum corneum 
provides the greatest resistance to penetration thereby 
limiting transdermal bioavailability of the drug and it is 
the rate limiting step in percutaneous absorption. Thus 
the transport of the drug across the skin membrane is a 
complex phenomenon. It is the cells of the stratum 
corneum which present the primary barrier to absorption 
of transdermally administered drugs. The drug molecule 
has to penetrate across the stratum corneum barrier in 
order to reach the deeper dermal region7. 
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Transdermal drug delivery system is a desirable form of drug delivery because of the obvious advantages over other routes of 
delivery. One promising challenge in designing transdermal drug delivery system is to overcome the natural transport barrier 
of the skin i.e. the stratum corneum which is the rate limiting step in percutaneous absorption of drugs. Various penetration 
enhancers are now being used alone or in combinations to enhance the penetration of the drug through the skin. The main 
objective of the present study is to review the synergistic action of various penetration enhancers on the efficacy and safety of 
the drug. It has been found from the literature study that systems employing synergistic mixtures of penetration enhancers 
offer superior skin permeation enhancement as compared to those employing single penetration enhancer. Various chemical, 
physical and carrier approaches have also been reviewed to increase skin permeation of the drug. 
Keywords: Transdermal, penetration enhancers, synergistic mixtures, permeation enhancement. 
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Approaches to increase skin permeation 
Chemical approach 
 Use of penetration enhancers (chemical and natural 
penetration enhancers). 
Carrier approach 
 Vesicular carriers 





 Microfabricated microneedles 
PENETRATION ENHANCERS: These are the 
substances that facilitate the absorption of penetrant 
through the skin by temporarily diminishing the 
impermeability of the skin. Penetration enhancers 
interact with structural components of stratum corneum 
i.e., proteins or lipids. They alter the protein and lipid 
packaging of the stratum corneum, thus chemically 
modifying the barrier functions of the skin leading to 
increased permeability of the drug through the skin. They 
are also known as accelerants, absorption promoters 
as they promote the penetration of topically applied 
drugs. Penetration enhancers can increase the drug 
diffusivity in the stratum corneum by dissolving the skin 
lipids or denaturing skin proteins. The type of enhancer 
employed has a significant influence on the design and 
development of the product.  
Permeability can be enhanced by altering the structure of 
the skin or by increasing the solubility of the drug in the 
skin. Various penetration enhancers are now being used 
in combinations to assess the plausibility of deriving 
synergistic benefits and to investigate their effect on the 
permeation and efficacy of the drug8. 
Ideal characteristics of penetration enhancer: It should be 
pharmacologically inert, non-toxic, non-irritating, non-
allergenic, compatible with the drug and excipients, they 
should not lead to the loss of electrolytes and body 
fluids, skin should immediately regain its barrier 
properties on its removal, it should readily formulate into 
dermatological preparations, transdermal devices and 
skin adhesives, it should be inexpensive and cosmetically 
acceptable. No single penetration enhancer can possess 
all the required properties. Several researchers are 
engaged in transdermal permeation studies using various 
penetration enhancers for several drug moieties9.  
Mechanism of penetration enhancer to enhance 
permeation of drug through skin: There are three main 
functions of penetration enhancers on the basis of lipid 
protein partitioning. First is the lipid disruption of the 
stratum corneum. The penetration enhancers modify the 
structure of the stratum corneum lipid organization and 
make it permeable to drugs so that drug can easily 
permeate through the skin. Second is the protein 
modification of the skin. They interact with keratin in 
corneocytes and open up the dense protein structure and 
make it more permeable for the drug. Third is the 
partitioning promotion, many solvents increase the 
partitioning of a drug, co-enhancer and co-solvent by 
changing the solution properties of the horny layer. Thus 
penetration enhancers act by altering the following path 
ways: 
i. Polar pathway: This pathway can be altered by 
protein conformational change. 
ii. Non-polar pathway: This pathway can be altered by 
altering the rigidity of the lipid structure. 
iii. Polar/non polar pathway: It can be altered by 
altering the multilaminate pathway for penetrants10. 
Penetration enhancers can be chemical and natural 
depending on their origin. 
CHEMICAL PENETRATION ENHANCERS: 
Various chemical penetration enhancers have been 
investigated for overcoming the stratum corneum barrier 
and enhancing the transdermal delivery of drugs. 
Chemical permeation enhancers are relatively 
inexpensive and easy to formulate, they offer flexibility 
in their design, are simple in application and allow the 
freedom of self administration to the patient11. 
Chemicals belonging to the same group can act on skin 
by different mechanisms depending on their individual 
physicochemical properties. 
Water 
Water is the most natural penetration enhancer. 
Hydration state of the stratum corneum is important in 
determining penetration enhancement of a given drug. 
Increased hydration of the stratum corneum enhances 
transdermal flux of a variety of drugs12. 
Hydrocarbons 
Several hydrocarbons including alkanes, alkenes, 
halogenated alkanes, squalane, squalene and mineral oil 
have been used as vehicles or penetration enhancers to 
increase permeation of a variety of drugs across the skin. 
These permeation enhancers work by partitioning into 
the stratum corneum and disrupting the ordered lipid 
bilayer structure13.  
Alcohols 
Alcohols are used as vehicles, solvents or penetration 
enhancers in improving transdermal delivery of drugs. 
These include alkanols, alkenols, glycols, polyglycols 
and glycerols. They can enhance skin permeation by a 
variety of mechanisms such as extraction of lipids and 
proteins, swelling of the stratum corneum or improving 
drug partitioning into the skin or solubility of the drug in 
the formulation14-17.  
Fatty Acids 
The most commonly studied chemicals in this category 
are fatty acids. These chemicals enhance transport of 
drug molecules across the skin by a variety of 
mechanisms such as partitioning into the lipid bilayers 
and disrupting their ordered domains, improving drug 
partitioning into the stratum corneum and forming 
lipophilic complexes with drugs. Examples include oleic 
acid and undecanoic acid. Oleic acid is an example in 
this category that is extensively studied as a permeation 
enhancer18-20. 
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Amines 
Primary, secondary and tertiary, cyclic and acyclic 
amines have been used successfully in enhancing skin 
permeation of a variety of drugs. Amines may enhance 
skin permeation by partitioning into the lipid bilayers or 
improving drug partitioning into the skin21. 
Amides 
Cyclic and acyclic amides form another large class of 
chemicals studied as permeation enhancers. Azone and 
its analogues along with pyrrolidones are the most 
extensively used amides22. 
Esters  
Esters of fatty acids have been used in several studies 
and show skin permeation enhancement of a wide variety 
of drugs. Isopropyl myristate is the most widely studied 
ester along with several other esters of fatty acids. These 
chemicals generally work by partitioning themselves in 
the ordered lipid domains of the stratum corneum23. 
Surfactants 
Surfactants are amphipathic molecules that consist of a 
non-polar hydrophobic portion usually a straight or 
branched hydrocarbon or fluorocarbon chain containing 
8-18 carbon atoms, which is attached to a hydrophilic 
portion. The hydrophilic portion can be nonionic, ionic 
or zwitterions. Many of the properties of surfactants can 
be related to their ability to concentrate at phase 
interfaces, leading to a reduction in interfacial tension. In 
biological systems the effect of surfactants are complex; 
particularly their effect on cell and other membranes, and 
this can lead to alterations in permeability characteristics. 
Nowadays, a wide variety of surfactants are being used 
as skin permeation enhancers. Surfactants are usually 
used with a vehicle or solvent system and their activity 
depends upon the hydrophilic to lipophilic balance, 
charge and lipid tail length. Anionic and non-ionic 
surfactants are relatively more widely studied2. 
Terpenes, terpenoids and essential oils 
Terpenes and terpenoids are usually the constituents of 
volatile oil. Terpenes have been utilized for a number of 
therapeutic purposes such as in antispasmodics, 
carminatives, perfumery and also as percutaneous 
absorption enhancers24. Terpenes are a popular choice for 
permeation enhancers in transdermal drug delivery 
system. This category includes a heterogeneous range of 
members and the effect of a specific terpene on skin 
depends upon its exact physicochemical properties, in 
particular its lipophilicity25.  
Sulfoxides 
Dimethyl sulfoxide (DMSO) was the first chemical to be 
studied in depth as a permeation enhancer. Dimethyl 
sulfoxide is the most important compound of this 
category. DMSO is an aprotic solvent that has the ability 
to induce cell fusion and cell differentiation and enhance 
the permeability of lipid membranes. It is also an 
effective cryoprotectant26. 
Lipids 
Phospholipids have been successfully used as permeation 
enhancers in the form of vesicles, microemulsions and 
micellar systems.  Phospholipids do not have an 
appreciable effect when interacting with the stratum 
corneum as individual molecules. However, in the form 
of self-assembled structures such as vesicles or micelles, 
they can fuse with the lipid bilayers of the stratum 
corneum thereby enhancing partitioning of encapsulated 
drug as well as disruption of the ordered bilayers 
structure14.  
NATURAL PERMEATION ENHANCERS: Natural 
oils as permeation enhancers have received increasing 
attention due to their better safety profile27. Vegetable 
oils have been found to be effective permeation 
enhancers due to the presence of fatty acids. In some 
cases fatty acids have been reported to be more effective 
than terpenes and azone28. They offer many benefits as 
they are safe to use, easily metabolized in the body, and 
are easily available. Examples include corn (maize) oil, 
jojoba oil, olive oil and groundnut oil etc29. 
SYNERGISTIC EFFECT OF PENETRATION 
ENHANCERS 
It has been reported in the literature that chemical 
penetration enhancers when used in combination or in 
different concentrations act synergistically to enhance 
the action of the drug by increasing the permeation of the 
drug through skin. A mixture of two or more solvents is 
one of the most widely studied formulation strategies to 
facilitate drug transport across the skin.  
Rhee et al., (2007) observed that the skin permeability of 
clebopride from a binary mixture of diethylene glycol 
monoethyl ether:isopropyl myristate (40:60) was 80-fold 
higher as compared to that from isopropyl myristate 
alone30. 
Krishnaiah et al., (2008) studied the effect of various 
water:ethanol solutions on skin permeation of 
ondansetron hydrochloride. They have found that a 
synergistic mixture of 60% v/v ethanol:water showed 
highest skin permeation in vitro31. 
Transdermal flux of highly lipophilic drugs such as 
antiestrogens can be enhanced by using a solvent 
combination of propylene glycol:lauric acid (90:10). The 
extraordinary permeation enhancement by this 
formulation is due to mutual permeation enhancement of 
these two enhancers and their synergistic lipid fluidizing 
activity in the stratum corneum32. 
Menthol:n-methyl pyrrolidone and isopropyl myristate:n-
methylpyrrolidone mixed solvent systems have also been 
documented to show synergistic enhancement of 
transdermal delivery of formoterol fumarate33. 
Binary combinations of isopropyl myristate and short 
chain alkanols show transdermal flux enhancement of 
estradiol when compared to alkanols alone34. 
Identification of synergistic mixtures of chemicals 
requires screening of a large number of chemicals and 
formulations for synergistic interactions35. 
Gwak et al., (2002) investigated the effect of vehicles 
and penetration enhancers on the in vitro permeation of 
tenoxicam from saturated solution through dorsal 
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hairless mouse skin. Various types of vehicles including 
ester, alcohol, and ether types and their mixtures were 
used as vehicles and then a series of fatty acids and 
amines were employed as enhancers respectively. The 
results revealed that the combination of lipophilic 
vehicles like oleic acid, linoleic acid or oleyl alcohol and 
hydrophilic vehicles like propylene glycol can be used 
for enhancing the skin permeation of tenoxicam36.  
Tezel et al., (2002) investigated the synergistic effect of 
ultrasound and surfactants on transdermal drug delivery. 
They found that surfactants possessing anionic and 
cationic head groups were more potent than those 
possessing nonionic head groups in increasing skin 
conductivity in the presence of ultrasound. Two 
mechanisms were shown to play a role on their 
synergistic effect. First, ultrasound enhances surfactant 
delivery into the skin and second, ultrasound disperses 
surfactant within the skin. They performed imaging 
experiments to assess the effect of ultrasound on delivery 
of a model permeant, sulforhodamine B into the skin37. 
Ganga et al., (1996) investigated the effect of azone on 
the transdermal iontophoretic transport of metoprolol 
tartrate through human epidermis in vitro. Investigations 
were carried out to see whether there is any synergistic 
effect of azone in conjunction with iontophoresis. Azone 
caused increased transport of the drug through human 
epidermis and the transport was increased 130 fold 
during iontophoresis compared to passive flux. The 
results were supported by scanning electron microscopy 
studies of the epidermis38. 
Kikuchi et al., (2005) studied the effect of EDTA and 
boric acid on the corneal penetration of CS-088, an 
ophthalmic agent. The corneal penetration of CS-088 
was significantly enhanced in the presence of EDTA/ 
boric acid by apparently 1.6 fold. The permeability 
enhancing effect of EDTA and boric acid was apparently 
synergistic and concentration dependent on both EDTA 
and boric acid39. 
Fang et al., (2008) studied the synergistic effect of 
menthol and ethanol on transdermal permeation and 
topical analgesia of tetracaine gel. To determine the 
efficacy of tetracaine gels for managing pain in human 
volunteers, a paralleled, double-blinded, placebo-
controlled, randomized controlled trial design combined 
with verbal pain scores was performed. 70% ethanol in 
5% methanol+ 70% ethanol/tertracaine gel not only 
improved the analgesic efficacy of the tetracaine gel 
through synergistically enhanced percutaneous 
permeation with methanol but also served as an 
antiseptic agent40. The in vitro skin delivery of 
furosemide was significantly improved by using a 
combination of oleyl alcohol and azone as permeation 
enhancers41. 
Mundada et al., (2012) have disclosed in their research 
that by using a range of penetration enhancers flux rate 
of the drug can be enhanced. They have reported the 
formulation of topical gel of lornoxicam by using a range 
of chemical penetration enhancers such as Transcutol P, 
Labrasol and triton X-100. The results revealed that 
transcutol P in 2% concentration showed maximum flux 
rate for lornoxicam across skin among all penetration 
enhancers42. 
Synergistic effect of eutectic mixtures 
Several eutectic systems of active drug along with a skin 
permeation enhancer have been studied in the literature. 
These systems are interesting since they provide two 
mechanisms by which skin permeation of an active drug 
across skin can be enhanced. In the first, they form a low 
melting mixture with the drug thereby improving its 
partitioning into the skin. In the second, they act on skin 
directly to disrupt its structure and further enhance drug 
permeation. This synergy in mechanism can be exploited 
by selecting the right permeation enhancer or enhancers 
to be combined with the drug. Eutectic systems of 
ibuprofen formed with terpenes and propranolol with 
fatty acids have been studied successfully for improved 
transdermal permeation of drugs43. 
Kang et al., (2000) showed that the lidocaine:menthol 
eutectic system enhanced permeation of lidocaine across 
shed snake skin44. 
Kaplun-Frischoff and Touitou showed enhanced 
permeation of testosterone across human cadaver skin 
when combined with menthol in a eutectic formulation45. 
Carrier approach and synergistic effect of vesicles 
Vesicles are colloidal particles that are composed of 
concentric bilayers formed from self-assembly of 
amphiphilic molecules. Synergistic interactions between 
the components of the vesicles and between the vesicles 
and skin constituents are believed to be responsible for 
the superior skin permeation enhancement of vesicular 
systems46. 
Liposomes consist of lipids such as cholesterol and 
phospholipids and they work by encapsulating drugs in 
their core and increasing their deposition in the stratum 
corneum47.  
Mezei (1985) showed that triamcinolone acetonide 
concentrations in skin were observed to be 4-5 fold 
higher when delivered from liposomes as compared to 
other conventional formulations. One limitation of 
liposomes is that they are less effective in delivering 
drugs to deeper layers of skin48. 
Niosomes are composed of non-ionic amphiphiles 
(surfactants) and are similar in function to the liposomes. 
Several studies have documented the superiority of 
niosomes in enhancing permeation of drugs across the 
stratum corneum.  
Paolino et al., (2007) have disclosed that Niosomes 
formulated from a new non-ionic surfactant alpha, 
omega-hexadecyl-bis-(1-aza-18-crown-6) (Bola-
surfactant), span 80 and cholesterol show significantly 
improved percutaneous permeation of ammonium 
glycyrrhizinate with respect to both the aqueous drug 
solution and a physical mixture between unloaded Bola-
niosomes and the aqueous drug solution49. 
Ethosomes are relatively new types of vesicle systems, 
primarily composed of water, ethanol and phospholipids.  
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Rao et al., (2008) demonstrated that the transdermal flux 
of fenasteride from ethosomal formulations was 2 to 7 
fold higher as compared to aqueous formulations50.  
Transfersomes are ultradeformable hydrophilic lipid 
vesicles that cross the skin under the influence of a 
transepidermal water activity gradient. Transfersomes 
consist of phospholipids and an edge activator that 
increases the deformability of the bilayers and is often a 
single chain surfactant such as sodium cholate, sodium 
deoxycholate, Span 60, Span 65, Span 80, Tween20, 
Tween 60, Tween 80 or dipotassium glycyrrhizinate51-56. 
Single chemical offer limited enhancement of skin 
permeability to drugs. Mixtures of chemicals can 
overcome this limitation owing to their synergistic 
interactions35. 
Physical techniques to increase transdermal drug 
delivery 
Iontophoresis:  It is a process which involves the 
transport of ionic or charged molecules into a tissue by 
the passage of direct or alternating electric current 
through an electrolyte solution containing the ionic 
molecules to be delivered using an appropriate electrode 
polarity. The process involves the transfer of ions into 
the body by an electromotive force. Ions with positive 
charge are driven into the skin at the anode and those 
with negative charge at the cathode. The current intensity 
should be increased slowly, maintained for the length of 
the treatment and decreased slowly at the end of the 
treatment. The current must be within comfortable 
tolerance of the patient with a current density less than 
0.5 m.amp/cm2 of the electrode surface. Placing a moist 
pad between the electrode plate and the skin is necessary 
for making a perfect contact. The drug should be applied 
through the electrode with correct polarity. The 
drawbacks associated with the iontophoresis technology 
include the possibility of electric shock, skin irritation, 
burns and cost of treatment6.    
Electroporation: The drawbacks associated with 
iontophoresis technology can be overcome to a certain 
extent by electroporation technology. This process 
involves the application of transient high voltage 
electrical pulse to cause rapid dissociation of the stratum 
corneum through which large and small peptides, 
oligonucleotides and other drugs can pass. The degree of 
enhancement achieved in-vitro is related to the applied 
voltage, number and duration of the pulses  offering the 
possibility of a controllable phenomenon6.  
Sonophoresis: This process involves the usage of high 
frequency ultrasound waves.  The application of low 
frequency ultrasound can increase the permeability of 
human skin to many drugs including high molecular 
weight proteins by several orders of magnitude, thus 
making transdermal administration of these molecules 
potentially feasible. Low frequency ultrasound is a non-
invasive technology for transdermal drug delivery 
system6. 
Microfabricated Microneedles: It is a novel technology 
which employs micron-sized needles made from silicon. 
Microneedles penetrate the skin about 10-15 mm deep 
inside the skin but do not reach the nerves found in 
deeper tissue, so are painless. These microneedle arrays, 
after insertion into the skin create conduits for transport 
of drug across the skin.  The drug after crossing the 
stratum corneum diffuses rapidly through deeper tissue 
and taken up by capillaries for systemic administration. 
A microprocessor is attached to a tiny pump for 
delivering tiny amounts of the drug. The microprocessor 
and the pump automatically inject the right dosage of the 
drug. They offer various advantages as they are 
mechanically strong, can be removed without difficulty 
as well as reinserted into skin multiple times6. 
SYNERGISTIC EFFECT OF CHEMICAL 
PENETRATION ENHANCERS AND PHYSICAL 
TECHNIQUES 
Various chemical penetration enhancers and physical 
permeation enhancement techniques have been 
investigated for overcoming the stratum corneum barrier 
and enhancing the trandermal delivery of drugs. Use of a 
combination of enhancers is reported to mutually 
enhance the efficacy and also increase the safety of 
drugs5. 
Combination of ultrasound and sodium lauryl sulfate 
(SLS) was reported to result in synergistic enhancement 
in permeation of mannitol by Mitragotri (2000)57.  
Oh et al., (1998) have reported that the transdermal 
transport of zidovudine was enhanced synergistically 
when iontophoresis was used in combination with 
chemical enhancers like propylene glycol and oleic 
acid58.  
Ganga et al, (1996) showed that the combination of 
azone and iontophoresis enhanced transdermal 
permeation of metoprolol synergistically38. 
Srinisava et al., (2011) have reported that the 
transdermal transport of drug was enhanced when 
magnetophoresis was used in combination with chemical 
penetration enhancers like menthol, dimethyl sufoxide, 
sodium lauryl sulfate and urea. The enhancement factor 
due to combination of chemical penetration enhancers 
was additive and not synergistic59.  
Makhmal Zadeh et al., (2010) have reported the effect of 
chemical and physical penetration enhancers on 
trolamine salicylate permeation through rat skin. 
Transcutol and eucalyptus oil were found to be the most 
effective enhancers60.  
 D.Prasanthi and P.K. Lakshmi (2013) have studied the 
synergistic effect of iontophoresis and chemical 
enhancers on transdermal permeation of tolterodine 
tartarate. They found that iontophoresis in combination 
with chemical enhancers like nerolidol, farnesol, tween 
20 and N-lauroyl sarcosine is an effective method for 
treatment of overactive bladder61. 
Johnson et al., (2000) studied the synergistic effect of 
chemical enhancers and therapeutic ultrasound on 
transdermal drug delivery. It was concluded that bilayer 
disordering agents such as linoleic acid and ultrasound 
transform the startum corneum bilayers into a fluid lipid 
bilayer phase or create a separate bulk oil phase, thereby 
producing greater enhancements for larger solutes62.  
CONCLUSION 
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Use of a combination of penetration enhancers is 
reported to mutually enhance the efficacy and safety of 
the drug by acting synergistically. Synergistic systems 
employing combinations of penetration enhancers are 
more efficient in enhancing skin permeability compared 
to individual enhancers. It has also been reported from 
the literature that side effects associated with physical 
techniques can be reduced when they are used in 
combination with chemical enhancers. 
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